Is it safe to use erythropoiesis-stimulating agents to treat anemia in chronic kidney disease patients with active malignancies?

Semin Dial. 2011 Jul-Aug;24(4):379-81. doi: 10.1111/j.1525-139X.2011.00929.x. Epub 2011 Jul 31.

Authors

Gaurav Gupta¹, Michael J Choi

Affiliation

¹ Division of Nephrology, Department of Internal Medicine, Johns Hopkins University, Baltimore, Maryland 21205, USA.

PMID: 21801225
DOI: 10.1111/j.1525-139X.2011.00929.x

No abstract available

MeSH terms

Anemia / drug therapy*
Anemia / etiology
Chronic Disease
Hematinics / adverse effects
Hematinics / therapeutic use*
Humans
Kidney Diseases / complications
Neoplasms / complications

Substances

Hematinics